000 01227 a2200397 4500
005 20250510211137.0
264 0 _c19790328
008 197903s 0 0 eng d
022 _a0361-5960
040 _aNLM
_beng
_cNLM
100 1 _aSimon, L N
245 0 0 _aIsoprinosine: an overview.
_h[electronic resource]
260 _bCancer treatment reports
_cNov 1978
300 _a1963-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHaplorhini
650 0 4 _aHerpes Simplex
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aInfluenza, Human
_xdrug therapy
650 0 4 _aInosine
_xanalogs & derivatives
650 0 4 _aInosine Pranobex
_xpharmacology
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPregnancy
650 0 4 _aRats
650 0 4 _aRhinovirus
650 0 4 _aVirus Diseases
_xdrug therapy
650 0 4 _aVirus Replication
_xdrug effects
700 1 _aGlasky, A J
773 0 _tCancer treatment reports
_gvol. 62
_gno. 11
_gp. 1963-9
999 _c81243
_d81243